Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N2DN
|
||||
| Former ID |
DNC008938
|
||||
| Drug Name |
4-Phenylspiro[chromene-2,4'-piperidine]
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529689] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H19NO
|
||||
| Canonical SMILES |
C1CNCCC12C=C(C3=CC=CC=C3O2)C4=CC=CC=C4
|
||||
| InChI |
1S/C19H19NO/c1-2-6-15(7-3-1)17-14-19(10-12-20-13-11-19)21-18-9-5-4-8-16(17)18/h1-9,14,20H,10-13H2
|
||||
| InChIKey |
AWYPHZMWGAOGIC-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [529689] | |
| Delta-type opioid receptor | Target Info | Inhibitor | [529689] | ||
| Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [529689] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathway | |||||
| PathWhiz Pathway | Muscle/Heart Contraction | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.